AGE Therapy Called Important in Treating Diabetic Patients


By: Daniel Trecroci

Australian researchers emphasize that therapies that inhibit the formation and accumulation of advanced glycation end-products (AGEs) or that “remove established AGE modifications” will be an important part of treating diabetics with kidney problems.

AGEs are caused by chronic high blood glucose and oxidative stress in diabetes.

“In particular, AGEs appear to have a key role in diabetic nephropathy,” they write. “Their importance as downstream mediators of tissue injury in diabetic kidney disease is demonstrated by animal studies using inhibitors of advanced glycation to retard the development of nephropathy without directly influencing glycemic control.”

American Journal of Therapeutics, November-December 2005



Diabetes Health Medical Disclaimer
The information on this site is not intended or implied to be a substitute for professional medical advice, diagnosis or treatment. All content, including text, graphics, images, and information, contained on or available through this website is for general information purposes only. Opinions expressed here are the opinions of writers, contributors, and commentators, and are not necessarily those of Diabetes Health. Never disregard professional medical advice or delay seeking medical treatment because of something you have read on or accessed through this website.